A number of previous studies have reported high expression of USP22 in specific malignant tumors, affecting the progression and prognosis of malignant tumors, including esophageal carcinoma and gastric, colorectal and breast cancer (10–13). The gene discussed is USP22; the disease is carcinoma of esophagus.